We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer.
- Authors
Lei, Yuanyuan; Lu, Zhiliang; Huang, Jianbing; Zang, Ruochuan; Che, Yun; Mao, Shuangshuang; Fang, Lingling; Liu, Chengming; Wang, Xinfeng; Zheng, Sufei; Sun, Nan; He, Jie
- Abstract
Melanotransferrin (MFI2) is a newly identified tumor-associated protein, which consists of two forms of proteins, membrane-bound (mMFI2) and secretory (sMFI2). However, little is known about the expression pattern and their relevance in lung cancer. Here, we found that both two forms of MFI2 are highly expressed in lung cancer. The expression of MFI2 in lung cancer was detected by using the public database and qRT-PCR. Overexpression and knockdown cell lines and recombinant sMFI2 protein were used to study the function of mMFI2 and sMFI2. RNA-seq, protein chip, ChIP assay, Immunoprecipitation, ELISA, and immunofluorescence were used to study the molecular biological mechanism of mMFI2 and sMFI2. We found that mMFI2 promoted the expression of EMT’s common marker N-cadherin by downregulating the transcription factor KLI4, which in turn promoted tumor metastasis; sMFI2 could promote the metastasis of autologous tumor cells in an autocrine manner but the mechanism is different from that of mMFI2. In addition, sMFI2 was proved could inhibit the migration of vascular endothelial cells and subsequently enhance angiogenic responses in a paracrine manner. We propose that the expressions and functions of the two forms of MFI2 in lung cancer are relatively independent. Specifically, mMFI2 was a potential lung cancer therapeutic target, while sMFI2 was highly enriched in advanced lung cancer, and could be used as a tumor staging index.
- Publication
Cell Death & Disease, 2020, Vol 11, Issue 10, p1
- ISSN
2041-4889
- Publication type
Article
- DOI
10.1038/s41419-020-03124-2